Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: Importance, challenges and future  by Sen, Saikat & Chakraborty, Raja
lable at ScienceDirect
Journal of Traditional and Complementary Medicine xxx (2016) 1e11Contents lists avaiJournal of Traditional and Complementary Medicine
journal homepage: http: / /www.elsevier .com/locate/ j tcmeReview articleRevival, modernization and integration of Indian traditional herbal
medicine in clinical practice: Importance, challenges and future
Saikat Sen*, Raja Chakraborty
Department of Pharmacy, Assam down town University, Panikhaiti, Guwahati, Assam 781026, Indiaa r t i c l e i n f o
Article history:
Received 27 February 2016







Clinical practice* Corresponding author. Tel.: þ91 9678210021.
E-mail address: saikat.pharm@rediffmail.com (S. S
Peer review under responsibility of The Center
National Taiwan University.
http://dx.doi.org/10.1016/j.jtcme.2016.05.006
2225-4110/Copyright © 2016, Center for Food and Bio
under the CC BY-NC-ND license (http://creativecomm
Please cite this article in press as: Sen S, Cha
practice: Importance, challenges and fut
j.jtcme.2016.05.006a b s t r a c t
In spite of incredible advances in modern science, technology and allopathic medicine a large we are
unable to provide quality healthcare to all. Traditional medicine particularly herbal medicine considered
as a major healthcare provider around the globe particularly in rural and remote areas. A large section of
people depends on such medicine for their primary healthcare mainly in underdeveloped or developing
countries. Indian traditional medicinal system like Ayurveda, Siddha and Unani has a very rich history of
their effectiveness; modern research also acknowledged the importance of such medicine. Indian
traditional medicine or medicinal plants are also considered as a vital source of new drug. Mainstreaming
of such medicine is important for the people. Several steps have been taken in India to promote such
medicine and to integrate them into clinical practice. Evidence based incorporation of Indian traditional
medicine in clinical practice will help to provide quality healthcare to all.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In last century, medical science hasmade incredible advances all
over the globe. Overall mortality rate decreased, expectancy of life
increased, a lot of new life saving drugs discovered which helps us
to ﬁght against several infectious and other diseases, and new
advancement in the ﬁeld of technology has boosted the capacity of
modern science. In spite of such incredible advancement whether
such beneﬁt of modern science/medicine has reach to the every
door of the world? World Health Organization (WHO) in an Inter-
national Conference on Primary Health Care in 1978 commonly
known as ‘Declaration of Alma-Ata’ express the need to achieve the
goal ‘Health for All’ step by step manner through tackling the
poverty, illiteracy and poor sanitation. In 1998, WHO incorporates a
newglobal health policy “Health for All in the 21st Century” and set
the goal to achieve health security, health equity, increased healthy
life expectancy and to ensure access to essential quality healthcare
for all.1,2 Modern medical science, despite so many achievements
and progress, is ﬁnding itself difﬁcult to reach to every people anden).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).
kraborty R, Revival, moderniz
ure, Journal of Traditionaldeal with the ever-increasing diseases and disorders. Still, majority
of world population mainly in developing and underdeveloped
countries does not have access to modern medicine and depends
on the time-tested traditional/alternative or complementary sys-
tems of medicine, many of these systems is much older compared
to the allopathic medical wisdom.3,4 Therefore, the major questions
still exist e (1) whether the goal has achieved? (2) whether ‘Health
for All’ can be possible without scientiﬁc integration of traditional
herbal medicine in clinical practice?
In the 21st century, pollution, unhealthy lifestyle, environ-
mental toxins increases the risk of diseases. The side effects, over-
use/misuses of allopathic drugs are also a major concern. In 2013,
WHO developed and lunched ‘WHO Traditional Medicine Strategy
2014e2023’ and emphasised to integrate traditional and comple-
mentary medicine to promote universal healthcare and to ensure
the quality, safety and effectiveness of such medicine.5 Therefore,
the world is looking for cost effective, easily available, better
physiological compatible traditional systems of medicine and ho-
listic approach to avert such problem and provide the basic
healthcare to all.
2. Indian society and traditional medicine
Knowledge regarding the therapeutic, toxicological effect of
plants, minerals and other substances go back to the prehistoricrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
ation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
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Several evidences indicated that in Indian subcontinent medical
intervention like dentistry and trepanation were exercised as early
as 7000 BCE. Current archaeo-botanical excavations pointed to-
wards the evidence regarding the use of medicinal plants in the
Middle Gangetic region since the 2nd millennium BCE which are
still found in Ayurvedic folk medicine.6 India is a land of different
group of people who have their own religion, beliefs, culture, lan-
guage and dialects. Thus, diverse medicinal systems have devel-
oped in this region. A number of medicinal systems also introduced
here from outside and enriched in India. Since ancient time, Indian
society depends on traditional medicinal systems practiced here.
Introduction of allopathic drug during British era and neglecting
Indian traditional medicine by British ruler are responsible for
signiﬁcant erosion of Indian traditional medicine. High scientiﬁc
progress in allopathic medicine and modern facilities also resists
the growth of traditional medicine. Still, about 70% rural pop-
ulations of India are believed in traditional medicine for primary
healthcare.7,8
2.1. Ayurveda
Ayurveda is a comprehensive scientiﬁc medicinal system
indigenous to India. The term Ayurveda means ‘knowledge of life’,
which comprises two Sanskrit words, Ayu (life) and Veda
(knowledge or science). Four Vedas, considered as the oldest In-
dian literature (5000e1000 BC) contain information about natural
remedies. Ayurveda was established as a fully grown medicinal
system.9,10 Charaka Samhita (focussing on internal medicine) and
Susruta Samhita (focussing on surgery) were written systemati-
cally and considered as classical text of Ayurveda. Vital details of
Charaka Samhita and Susruta Samhita were complied together and
updated additionally in Astanga Sangraha and Astanga Hrdaya.
Some other ancient classics which include minor work of Ayur-
veda includes Madhava Nidana (focussing on diagnosis of disease),
Bhava Prakasa (focussing on additional information related to
plant and diet), Sarngadhara Samhita (focussing on formulation
and dosage form).9,11 Ayurveda was divided into eight major
clinical subdivisions e Kayacikitsa (internal medicine), Salya Tantra
(surgery), Salakya (diseases of supra-clavicular origin), Kaumar-
abhrtya (paediatrics, obstetrics and gynaecology), Bhutavidya
(psychiatry), Agada Tantra (toxicology), Rasayana Tantra (rejuve-
nation and geriatrics), Vajikarana (aphrodisiology and
eugenics).9e11
2.2. Siddha
Siddha system of medicine is believed as a brilliant achievement
and symbol of Tamil culture which originated in Southern parts of
India. Siddha medicine invented from Dravidian culture and is
grown in the time of Indus valley civilization. Chinese alchemy,
Taoism, and Taoist Patrology are considered as a main source of
inspiration for Siddha alchemy. It is believed that in ancient time,
the system was developed by eighteen siddhar (a class of Tamil
sages). Though Siddha system of medicine resembles with Ayur-
veda in many aspects it has own philosophy and concept, holistic
approach, and lifestyle oriented measures.12e15
2.3. Unani
Unani system of medicine is the fusion of contemporary tradi-
tional medicinal system in Egypt, Syria, Iran, Iraq, China, India and
several other east countries. It was originated in Greece and letter
developed in Arab. Arab and Persian settlers in 11th centuryPlease cite this article in press as: Sen S, Chakraborty R, Revival, moderniz
practice: Importance, challenges and future, Journal of Traditional
j.jtcme.2016.05.006introduced Unani medicine in India, the system gets recognition
and enriched during Mughul rule.16e18
2.4. Amchi
Amchi or Sowa-Rigpa is another ancient well documented
traditional medicinal system, which was popular in Tibet,
Mongolia, Nepal, Bhutan, Himalayan region of India, some parts of
China and former Soviet Union. Though conﬂicts exist on the origin
place of Amchi medicine as some believed it originated in India,
some say Tibetan region and other considered it as Chinese origin.
Amchi has close similarity with Ayurveda, though inﬂuence of
Chinese traditional medicine and Tibetan folklore also observed in
this system.19
2.5. Folk medicine
Other than codiﬁed traditional medicinal system the uncodiﬁed
folk medicine also plays a vital role in maintenance of health and
cure of diseases for large number of people belongs to rural/
indigenous/ethnic communities. This type of knowledge is not
documented properly and propagates verbally from ancestors.
Nearly 8000 plants species are utilized in folk medicine and
approximately 25,000 effective plant-based formulations used by
the rural and ethnic communities in India.17
3. Herbal medicine and its importance
Plants are always the key source of drug or treatment strategy in
different traditional medicinal systems. In recent years, many
people are choosing to plant based medicines or products to
improve their health conditions or as curative substance either
alone or in combination with others. According to the WHO, herbs
or herbal products are used by the large number of populations for
basic healthcare needs. Herbal medicine includes herbs, herbal
materials (like plant parts) or preparations, processed and ﬁnished
herbal products, active ingredients.20,21 In recent years, a huge
resurgence of the use of herbal product due to the side effects of
modern drugs, failure of modern therapies for against chronic
diseases, and microbial resistance. It is estimated that nearly 75% of
the plant based therapeutic entities used worldwide were included
from traditional/folk medicine. In India, approximately 70% of
modern drug are discovered from natural resources and number of
other synthetic analogues have been prepared from prototype
compounds isolated from plants.20,22,23 It was reported that more
than 60% of cancer drug available in market or in testing are based
on natural products. Currently, about 80% of antimicrobial, immu-
nosuppressive, cardiovascular, and anticancer drugs are derived
from plant sources. More than 70% entities among 177 anticancer
drugs approved are based on natural products or mimetic. About
25% prescription drug found globally are derived from plant sour-
ces, and nearly 121 such drugs entity are in use. Thirteen drugs of
natural origin are approved in United States between 2005 and
2007, and clinical trials are going on more than 100 natural
product-based drugs. It was also estimated that 11% of the total 252
drugs found in essential medicine list of WHO are exclusively of
plant origin.24,25 In Indian traditional medicine a large number of
plants are used. It was estimated that Ayurveda uses 1200e1800
plants, Siddha medicine includes 500e900 plants, Unani utilize
400e700 medicinal plants and Amchi medicine uses nearly 300
plants while folk healers of India use more than 7500 medicinal
plants in different medicine. Three classical Ayurvedic literature
Charaka Samhita, Sushruta Samhita and Astanga Hridaya
mentioned about 526,573 and 902 number of plants.17,26,27ation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
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addressed
In spite of global reorganization and very sound history of
traditional uses, promotion of herbal medicine faces number of
challenges around the glove mainly in developed nations.
Following problems need to be overcome before the promotion of
traditional herbal knowledge around the world.28e34
 Quality issues: Adulteration, misidentiﬁcation of plant, faulty
collection and preparation, incorrect formulation process are
the main problems that reduces the effectiveness of herbal
preparation and can be considered as key factors affecting
quality and purity of herbal medicines.
 Processing and harvesting issues: Indiscriminate harvesting, poor
agriculture and propagation method, poor pre and post harvest
practices, lack of processing techniques leads to the substandard
quality of herbal drugs.
 Quality control related issues: Standardization, poor quality
control procedure and lack of Good Manufacturing Practices
(GMP) are the main hurdle to maintain the quality of herbal
drugs. Lack of awareness regarding the guideline among
growers and manufacturers, lack of implementation and regu-
lation of the guideline are also frequent in small and medium
scale industries.
 Administrative issues: Lack of regulation and controlling au-
thority in herbal sector, lack of proper monitoring and control-
ling are absolute need for the quality of drugs.
 Infrastructure related issue: Lack of processing technique, trained
personal, sophisticated instrument, utilization of modern tech-
niques, facility to fabricate instrument locally are the major
problems.
 Pharmacogivilane: Proper pharmacogivilane in herbal sector is
the need of time to ﬁnd the toxicological data and adverse drug
reaction of herbal drugs. Adverse reactions, contraindications,
interactions with other drug, food and existing orthodox phar-
maceuticals need to be monitor properly.
 Clinical trial: Since the safety continues to be a foremost issue
with the use of herbal remedies therefore, clinical trials are
necessary to understand the safety and efﬁcacy of these drugs
before introduced them in global market.
 IPR and biopiracy: Biopiracy is the major difﬁculty in promotion
of herbal traditional medicine. Documentation of folk knowl-
edge thus important for our future.
 Irrational use: It is generally believed that herbal products don't
have any side effects, interaction, but unfortunately is not true.
Thus, irrational practice of these drugs can lead to various
problems which can hinder the promotion of such drugs.
 R&D: Research and development on dosage, processing, tech-
niques are the key need for any drug, but in herbal sector it is
quite less compare to allopathic medicine. Although in recent
years, the trend is changing. Research to understand themode of
action and pharmacokinetics phenomenon, improvement/cre-
ation of monographs and reference standards for marker-based
analysis are necessary of time. Decisive gap in current ethno-
pharmacological and modern medicinal plant research is
another problem for sustainable, socio-culturally equitable and
safe supply of herbal medicines.
 Other issues: Unethical practice of herbal medicine, lack of
qualiﬁed physician, exposure of unreliable and misleading in-
formation, lack of sufﬁcient fund, absence of focused marketing
and branding, lack of knowledge sharing also hold back the
global promotion of herbal medicine. Lack of protection of
biodiversity and protecting the traditional medicinal plants are
also a big challenge.Please cite this article in press as: Sen S, Chakraborty R, Revival, moderniz
practice: Importance, challenges and future, Journal of Traditional
j.jtcme.2016.05.0065. Modernization & integration of herbal medicine in clinical
practice e experience from India
In spite of number of hurdles, the traditional medicine of India
in acknowledged widely around the world and the demand is
increasing continuously. Combined effort of public and government
sector is essential for the promotion of herbal medicine. Here we
are discussing about the situation and possibilities of promotion of
Indian traditional herbal medicine in India.5.1. Rules, regulation & governing body
In India, the national policy on traditional and alternative
medicine was introduced in 1940 in the form of Drug and
Cosmetic Act 1940 and Drug and Cosmetic Rule, which was
updated in several instate. In 1959, Govt of India recognized
traditional Indian System of Medicine (ISM) and updated Drug
and Cosmetic Act. Several expert committees for different ISM
were established time to time and the earliest was established in
1962. In the year 1969, separate chapter related to Ayurveda,
Siddha and Unani drugs was inserted by act 13 of 1964 in the Act,
which partly similar as those for conventional pharmaceuticals.
Later the act was modiﬁed again with some substitutions in the
year 1983, 1987, 1994 and 2002. In 2006 and 2008 guideline for
evaluation and analysis of drugs under ISM was given under
Drug and Cosmetic Rule 1945. The Central Council of Indian
Medicine (CCIM) is constituted in the year 1970, which involved
in the framing and implementing different regulations including
the curricula and syllabii in ISM (i.e. Ayurveda, Siddha and
Unani). In 2012, Sowa Rigpa system of medicine is incorporated
in the CCIM. Department of Indian Medicine and Homeopathy
(ISM & H) was formed with the objective to develop the ISM. In
2003, this Department was renamed as Department of Ayurveda,
Yoga and Naturopathy, Unani, Siddha and Homoeopathy
(AYUSH), and in 2014 separate ministry on AYUSH was
formed.35e395.2. AYUSH and health policy
Department of AYUSH concentrates on the overall governance,
education, regulation, development and growth of ISM in the India
and abroad. The department has few subordinate ofﬁces, several
autonomous bodies in the form of research councils, professional
council, pharmacopoeia laboratories, national institutes, academy
and hospitals. In the year 2002, National Policy on Indian Systems
of Medicine & Homoeopathy was introduced. Major objectives of
this policy are,37,40
 Utilize the AYUSH to endorse good health and spread out the
outreach of healthcare to our people (mainly who cannot afford
or reach to themodern healthcare facilities) through preventive,
promotive, mitigative and curative approaches.
 To provide affordable AYUSH services & drugs which are safe
and efﬁcacies;
 To ensure the availability and genuine of raw drugs as required
by pharmacopoeial standards to help improve quality of AYUSH
drugs, for domestic and/or export purpose.
 Incorporate AYUSH in healthcare delivery system and na-
tional programmes and to ensure the best possible utilization
of huge infrastructure of hospitals, dispensaries and
physicians.
 To offer full opportunity for the expansion and development of
ISM and utilization of the potentiality, strength and revival of
their glory.ation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
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In India, several legislative and administrative measures are in
place to control the manufacturing and sale of Ayurveda, Siddha
and Unani (ASU) medicine. Chapter IVA in the Drugs & Cosmetics
Act, 1940 describe the provisions for regulation of manufacturing,
packaging, labelling and sale of ASU drugs. Periodic revision of such
act is also a part of betterment of ASU drugs, as the latest amend-
ments in this chapter were done on March 2013. A separate Ayur-
veda, Siddha and Unani Technical Advisory Board (ASUDTAB) was
also formedwhich deals and advice the authorities on the technical
matters involved in the regulation of ASU drugs. Another Ayurveda,
Siddha and Unani Drugs Consultative Committee (ASUDCC) also
constituted which advice to attain the uniformity in the adminis-
tration of Drugs & Cosmetics Act, 1940 (related to ASU drugs)
throughout India. GMP for ASU drugs was under Schedule ‘T’ of the
Indian Drugs & Cosmetics Act, 1940 and Rules, 1945 was notiﬁed in
2000. In view of world concern related to the presence of heavy
metals in ASU drugs guideline was issued to test the ASU drug to
ﬁnd the presence of heavymetal and check the limit of heavy metal
if any. Guidelines have also been issued to curb growth of irrational
ASU combinations.40,41
Several rules/guidelines like inclusion of proper botanical name
in label, include the caution regarding the consumption of drug
under medical supervision if ingredient contain any hazardous/
other substance speciﬁed in Schedule E(1) of the Drugs and Cos-
metics Rules 1945, introduction of rule regarding the maintenance
of records of raw materials, guideline of permitted excipients along
with their standards, law to test heavy metals, stipulation of expiry
date for Ayurvedic medicines.42
In 1970, Pharmacopoeial Laboratory of Indian Medicine was
formed to ensure standardization and testing of ASU drugs. Several
others government recognized laboratories are also involved to lay
down pharmacopoeial standards, preparation of monographs and
Standard Operating Procedures (SOPs) for ASU drugs. Pharmaco-
poeial committees for ASU systems involve in the lay down of
standards for quality, purity and strength of drugs and approve
drug formularies. Pharmacopoeial Laboratories, Central Council for
Research in Ayurveda and Siddha (CCRAS) laboratories, laboratories
of Central Council for Research in UnaniMedicine (CCRUM), Council
for Scientiﬁc & Industrial Research (CSIR) laboratories and several
other laboratories of private sector are involved in the mammoth
job of controlling and maintaining of quality, formulation of stan-
dard for ensuring safety and quality of polyherbal/herbomineral
preparations.17,40,41
5.4. Pharmacopeias and formularies
Both traditional and modern parameters are used to test the
quality and to standardize the raw and ﬁnished products. Several
methods like organoleptic standardization of drugs, chemical
investigation, and bioassay are used in this regard. Ayurvedic
Pharmacopoeia of India (Part I contain eight volumes and Part II
contain three volume of compound formulation), Unani Pharma-
copoeia of India (Part I on signal drug contain six volume, Part II on
formulation contain two volume), Siddha Pharmacopoeia of India
(volume I and II), Ayurvedic Formulary of India (Part I & II), Unani
Formulary of India (Part IeVI), Siddha Formulary of India (Part I &
II) are playing a signiﬁcant role in this area. Pharmacognostical,
chemical and standards of the plant drugs used in ISM are
mentioned in such publications. These pharmacopoeias and for-
mularies contain information about the biological source, syno-
nyms, description, TLC, important formulation, therapeutic
indication, and details related to identity, purity, strength. Recently,
chromatographic ﬁngerprint proﬁle as a supplementary toPlease cite this article in press as: Sen S, Chakraborty R, Revival, moderniz
practice: Importance, challenges and future, Journal of Traditional
j.jtcme.2016.05.006Ayurvedic Pharmacopoeia was also published. Identiﬁcation and
estimation of active therapeutic ingredients and marker com-
pounds with reference to which drugs of Ayurveda, Siddha and
Unani can be standardized are still developing and all these pa-
rameters are being added to pharmacopoeias. Inclusion of mono-
graph on herbal drug in Indian Pharmacopeia and formulation of
Herbal Pharmacopeia are also a major step to achieve the goal.
Alongwith pharmacopoeias and formularies other publications like
‘Production of ISM Drugs with Current Good Manufacturing Prac-
tices’, ‘Quality Standards of Indian Medicinal Plants’ could also be
useful to maintain the standard and quality of ISM.37,42e44
5.5. Research, industry, education and practice
Several research works are going on the ASU drugs. Basic
research to preclinical or clinical study, investigation on standard-
ization and formulation on ISM are a hot area of research in current
time. Central Council for Research in Ayurvedic Sciences, Central
Council for Research in Unani Medicine, Central Council for
Research in Siddha, Central Council for Research in Yoga & Natu-
ropathy, CSIR, Central Drug Research Institute (CDRI), several pri-
vate research centre, institution and universities are actively
engaged in research, development and promotion of traditional
herbal medicine.
Nearly, 9000manufacturing units of Indian TraditionalMedicine
are present in the India as on April 2013. Though the majority of
them (7744) are involved in manufacturing of Ayurveda drugs,
whereas, 485, 344 and 323 manufacturing units were engaging in
manufacturing of Unani, Siddha and Homoeopathy drugs respec-
tively. Statistics also suggest that only 0.1% per annum growth was
observed realized in total AYUSH drug manufacturing units during
last two decade. A recent statistics showed that among the 10,000
Ayurvedic, Siddha and Unani medicine manufacturing unit about
54% is GMP complying units.37,45
CCIM was established under the Indian Medicine Central
Council Act, 1970 and involve in the regulation of education and
practice of ISM. A signiﬁcant increase in AYUSH colleges/teaching
institutions has been experienced in last two decade. In 2013, more
than 500 AYUSH under graduate colleges with admission capacities
more than 25,000 was recorded in India. Ayurveda have 261 under
graduate colleges, whereas Homoeopathy, Siddha, Unani and
Naturopathy have 188, 9, 41 and 17 under graduate colleges
respectively. More than 125 post graduate colleges (Ayurveda 76,
Homoeopathy 40, Siddha 3, Unani 8) with more than 2700
admission capacities were in existence in the India in 2013. Na-
tional Institute of Ayurveda (Jaipur), National Institute of Natu-
ropathy (Pune), Institute of Post Graduate Teaching and Research in
Ayurveda (Jamnagar), National Institute of Unani Medicine (Ben-
galuru), National Institute of Siddha (Chennai) are some of the apex
educational institute of traditional medicine in India. Several
courses like Bachelor Degree Medicine and Surgery in different
Indian System of Medicine, Doctor of Medicine (MD), Doctor of
Surgery (MS), PG Diploma Courses, Diploma Citiﬁcation Courses,
PhD courses in several branches of ISM are being offered by the
several institutions Certiﬁcate course, Currently Pharmacy Degree
i.e. D. Pharm, B. Pharm,M. Pharm in Indian traditional medicine also
started.40,45,46
It was counted more than 3100 AYUSH hospitals with 57,056
beds strength runs in India as on April 2013. Maximum number of
hospitals are on Ayurveda (2408), whereas, 255, 267, 29, 201 and 7
hospitals pertain to Unani, Siddha, Naturopathy, Homoeopathy and
Yoga systems respectively. More than 26,000 AYUSH dispensaries
also deliver the primary healthcare facility around the country.
Number of dispensaries in Ayurveda, Unani, Siddha, Yoga, Natu-
ropathy, Homoeopathy and Sowa-Rigpa recorded as 15,927, 1483,ation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
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registered practitioners (maximum 387,976 practitioners have
been registered under Ayurveda System) were available which is
increasing continuously. The number of Institutionally Qualiﬁed
(IQ) registered practitioners has also been increased in last few
years, in 2013 the total number of IQ registered practitioners was
461,032.40,455.6. Traditional knowledge digital library (TKDL)
TKDL is an exclusive digital database regarding the medical
knowledgementioned in several ISM that are available in the public
domain. The database consists the information about the medicinal
plant, formulation of Ayurveda, Siddha, Unani, Yoga etc. TKDL is a
collaborative project of CSIR and AYUSH, and the information's are
also available in different national and international language.
TKDL contain information of 500 Ayurvedic, 500 Unani and 200
Siddha formulations. The information from 150 Ayurvedic/Siddha/
Unani books is incorporated in TKDL. The access to 2.5 lakh me-
dicinal formulations different to Patent Ofﬁces under TKDL access
agreement is considered as unique process to protect traditional
knowledge from biopiracy. Based on the third party notes sub-
mitted by the TKDL, so far a large number of patent applications in
European Patent Ofﬁces, Canadian Intellectual Property Ofﬁce,
United States Patent and Trademark Ofﬁce, United Kingdom Patent
and Trademark Ofﬁce, Controller General of Patents, Designs and
Trademarks, India has been either set aside, or withdrawn/
cancelled, or declared dead.345.7. Promotion, gradual integration
There has been a steady policy support to promote the tradi-
tional medicine in India. The government also supporting different
plans related to research-development related to medicinal plant
research. The budget allocation for the Dept of AYUSH has been
increasing gradually over the years. In the 12th Five Year Plan of
India (2012e2017), total allocation for AYUSH was INR. 10,044
crore, which was 235% more than the actual expenditure of 11th
Plan.47 In the view of integrate the AYUSH system for healthcare
system several policies are formulated,40,48,49 like:
 Utilization of AYUSH doctors in National Reproductive & Child
Health and Population stabilization programmes
 Inclusion of several traditional drugs (i.e. Ayush Ghutti, Bal
Rasayana, Soubhagya Shunthi, Ark Ajwain, Ark Pudina, Punarna-
vadi Mandoor and Ksheerbala Tel.) in the National Reproductive
& Child Health (RCH) Programme for use bymothers& children.
 A pilot project to monitor the effect of Ayurveda treatment in
the ante-natal and post-natal care
 Utilization of available facilities of ISM in rural health care
mission (NRHM). Like, appointing Ayurveda doctors and para-
medics in the primary healthcare delivery system and in Na-
tional Health programs.
 Inclusion of AYUSH drug (i.e. Punarnavadi mandoor for man-
agement of anaemia during pregnancy) kit of ASHA (ASHA or
Accredited Social Health Activist act as an interface between the
community and the public health system in rural India) in
addition to generic drugs for common ailments at sub-centre/
primary health centre/community health centre.
 Ensure the availability of Ayurvedic, Siddha and Unani essential
drug to primary health centre.
 To ﬁnd the way of inclusion of AYUSHmedicine in schemes such
as Janani Suraksha Yojana (JSY-AYUSH), ICDS-AYUSH, Repro-
ductive Child Health (RCH), early breastfeeding, growthPlease cite this article in press as: Sen S, Chakraborty R, Revival, moderniz
practice: Importance, challenges and future, Journal of Traditional
j.jtcme.2016.05.006monitoring of children, ante and post natal care, etc. And ﬁnd
their effectiveness.
Recently, there are some suggestion to allow the AYUSH doctor
to prescribe modern medicine if rural areas in view of shortage of
allopathic doctors. But there is strong oppose as it may violate the
rule present in India.50 Fig. 1 describes the strategy of integration of
traditional herbal medicine in clinical practice.
Collaboration, establishment of research institute in foreign,
conduct of seminar-conferences are the key way to promote the
ISM globally. AYUSH opened an Indo-US joint Center for Research
on Indian Systems of Medicine (CRISM) at the University of Mis-
sissippi USA in 2008. Ayurveda Education & Research, Gujarat Ay-
urveda University, Jamnagar singed a MoU with institutions in
Japan, Australia, Netherlands, Argentina, Italy, and USA. Several
other national institutions also have MoU with foreign institutions
in the ﬁeld of research and education in ISM. Institutions of India
offering various courses for the students from Japan, Russia, South
Africa, Netherlands, France, Hungary, Canada, USA, Poland, Ger-
many, Brazil, Switzerland, Ukraine, Sri Lanka etc. related to Ayur-
veda. India and Russia had concluded a MoU on the cooperation in
the ﬁeld of Ayurveda teaching, treatment and research. In 2004,
Russian-Indian Centre on Ayurvedic Research was established in
Moscow.40,51
5.8. Protection of biodiversity
Protection of biodiversity and conservation ofmedicinal plants is
essential for the livelihood security and ensure the availability of
medicinal plant in future. AYUSH drug manufacturing units use
almost 90% of the raw materials of medicinal plants from natural
forests, but during such processwe overlook the environmental and
social issues. Therefore, sustainable use of medicinal plants and
good ﬁeld collection practice is important. In situ (conservation of
plants in their natural habitat outside the native habitat) and ex situ
conservation (like, seed storage, DNA storage, pollen storage, in vitro
conservation, ﬁeld gene banks and botanical garden etc) are the key
approaches to protect and conserve medicinal plant species.52,53
6. Indian traditional medicine e revival story and
globalization
In recent years there is a huge upserge in the use of traditional
and complementary medicine around the glove. In Africa nearly
80% of population uses such medicine for their primary healthcare.
In China, it was estimated that traditional herbal medicine account
for 30e50% of the total medicinal consumption. Majority of the
people (around 60%) uses traditional herbal drugs as a ﬁrst line
medicine for treatment high fever resulting from malaria in coun-
tries like Ghana, Mali, Nigeria and Zambia. In Australia about 48%, in
Canada 70%, in Germany 80%, in USA 42%, in Belgium 39% and in
France 76% of population uses traditional/complementarymedicine
at least once. Around 75% of the HIV positive/AIDS patients living in
San Francisco, London and South Africa use traditional and com-
plementary medicine. In Malaysia, people spent more on tradi-
tional medicine than allopathic drugs. Importance of herbal
medicines in terms of healthcare provider and economy are
growing steadily.53e55 Therefore, India has a great opportunity to
promote ISM globally.
6.1. Ayurvedic drugs around the globe
Ayurveda is well recognized in Asian countries like Nepal, Sri
Lanka, Bangladesh and other Asian countries. About 75% of 100
million subcontinental people are enjoying the beneﬁts ofation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
Fig. 1. Strategy in include traditional medicine in regular healthcare service in India.
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Ayurveda in 1969, and since last 40 years study, research and
spread of Ayurveda is being carried out passionately. Ayurveda is
also popular in Thailand, Myanmar. Education and practice of Ay-
urveda is ﬂourishing in many states of USA. ISMmainly Ayurveda is
increasing in Argentina, Brazil, Venezuela, Chile, Nicaragua, Costa
Rica, Guatemala, Germany, Austria, Switzerland, France, Czech Re-
public, Greece, Israel. Countries like South Africa, UAE, Russia,
Sweden, Indonesia, Netherlands, Italy, Spain, Australia, New Zea-
land, Hungary have acknowledged Ayurveda. Several other coun-
tries are on the verge of doing the same.56,57
6.2. ISM, medicinal plants of India and economy
Approximately 25,000 effective plant-based formulations are
available in ISM which is commonly used by rural and ethnic
people n India and the popularity of such medicine is also
increasing among the common people. It was also estimated that
>2000 tons of medicinal plant raw material is required annually.
More than 1500 herbals are also sold as dietary supplements or
ethnic traditional medicines. It was also estimated that nearly 960
species of medicinal plants are in trade, among them 178 species
have annual consumption levels more than 100 metric tones. Do-
mestic trade of AYUSH industry is approximately INR. 80e90
billion, and export value of medicinal plants and related products
from India is approximately l10 billion. In 2012e2013, the export of
AYUSH products was INR. 24,741.2 crores, though in next ﬁnancial
year (2013e2014) it was reduced slightly. The percentage share of
AYUSH products in the total trade of India in 2013e2014 was 0.36%.
The global market for herbal drugs is increasing in steady manner
and the global herbal trade will reach USD 7 trillion by 2050.8,17,58
6.3. Preventive and curative approaches of ISM
Ayurveda and other ISMs are involved in the curative and pre-
ventive measures to promote the health. Rasayana (rejuvenationPlease cite this article in press as: Sen S, Chakraborty R, Revival, moderniz
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j.jtcme.2016.05.006therapy), branch of Ayurveda involve in the preservation and pro-
motion of health by promoting longevity and also prevents or de-
lays the ageing process, which another speciality of Ayurveda
namely ‘Panchakarma’ (puriﬁcation therapy) removes the toxins
and waste materials from the body and thus purify the biological
system to disease completely.10 Ayurvedic formulations are highly
effective against various common diseases like common cold, fever,
hyperacidity, ulcer, cough, gastro-intestinal problems, diarrhoea,
amoebic dysentery, liver diseases, uterine bleeding, urinary tract
infection, arthritic condition, gout, bronchial asthma, eye diseases
etc. at the primary healthcare level. Formulation of Ayurveda also
shown prominent effect in the treatment of several chronic dis-
eases like cardiovascular disease (hypertension, angina, cardiomy-
opathies, myocardial infarction, congenital heart disease), cancer,
dengue, anti-inﬂammatory disease, kidney diseases etc.59e63 Some
studies have suggested that Ayurvedic medicine is also useful to
manage some emergency conditions like severe diarrhoea and
vomiting, patient suffering from typhoid suffered from semi con-
sciousness and also muttering delirium, burns and seals, poison,
threatened abortion, abortion & miscarriage etc.64 Medicine from
Siddha system is used to cure diverse diseases like skin problems
(psoriasis), sexual transmitted diseases, urinary tract infections,
liver and gastro-intestinal diseases, diabetes, general debility,
postpartum anaemia, diarrhoea, rheumatic diseases, prostate
enlargement, bleeding piles, peptic ulcer, venereal diseases, fever,
allergic disorders and general fevers other than emergency
cases.65,66 Unani drugs are used to treat hepatitis, gastroenteritis &
uteritis, fever, cardiovascular problems, palpitation, nausea, vom-
iting, diarrhoea, gastro intestinal trouble, fever, insomnia, schizo-
phrenia, epilepsy, gonorrhoea, urinary tract infection, kidney stone,
headache, dizziness, common cold, migraine, colic pain, arthritis,
syphilis, paralysis, diabetes insipidus, bad wetting, anxiety, typhoid
fever, measles, small pox, premature ejaculation etc.67 ISMs are also
found useful for care of HIV/AIDS patients.68 Medicinal plants found
in India and utilized by the different folk and codiﬁed medicine are
utilized to cure diverse diseases.ation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
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Effectiveness of ISM particularly Ayurveda has been evident in
sub-continent as people enjoys the beneﬁt of such medicine since
the pre-biblical era. Core strength in these systems is the holistic
approach to health and disease using natural substances derived
from medicinal plants, minerals and animal sources.69 But in cur-
rent situation proper clinical trial, quality assurance and pharma-
cogivilance are the important area to promote such drug
worldwide. In recent year's national and international level, a lot of
clinical studies are conducted to prove effectiveness of ISM. In-
crease research on medicinal plants and ISMs results raise in clin-
ical studies. A number of collaboration in this sector has been
increasingly attracting several entrepreneurs and organizations.
AYUSH research portal (http://ayushportal.nic.in/) included infor-
mation regarding 4175 clinical trial, 8514 pre-clinical research,
6002 drug research and 2926 fundamental research information
related to ISM or plants used in these systems as on January 2016.70
Safety evolution and to ﬁnd the mode of administration or use also
a critical criteria of these study. For example, a study showed that
polyherbal drug, AB-FN-02 having signiﬁcant anti-osteoarthritic
effect and non-toxic when administered in traditional method
with milk, but it may produce toxic effect when administered as a
drug otherwise. Indian Council of Medical Research database also
contain information about folk medicinal plants. Information about
500 medicinal plants/formulations used by folk medicine practi-
tioners (non-codiﬁed system) was included and currently scientiﬁc
validation (safety, efﬁcacy, mode of action and clinical trials) of few
selected leads are going on different parts of India.71 Although it is
true that proper high value clinical trial of such medicine is
comparatively les due to small size of population, problems with
research designs, lack of appropriate control groups etc.
6.5. Indian medicinal plants and drug discovery
Drug discovery from medicinal plants used in different Indian
medicinal systems is a hot spot of research. A number of drugs were
obtained from the plant sources and several others have discovered
by using natural substance as lead. Investigations in India and
abroad became played a key role in such research. In 1931, Sen and
Bose reported two alkaloids from Rauwolﬁa serpentina, Siddiqui
and Siddiqui in same year isolated ﬁve alkaloids which named as
Ajmaline, Ajmalinine, Ajmalicine, Scrpentine, and Serpentinine.
Chopra and his colleagues in 1933 isolate an alkaloid from the plant
and observed the hypotensive and CNS depressant activity. Several
others investigations had also been made by the Indian researchers
in subsequent years. In 1949, a historical paper by Dr Vakil in British
Heart Journal reported the antihypertensive activity of Rauwolﬁa in
patients. During that time nearly 90% of doctors in India used it as a
routine hypotensive drug and about 50 million tablets had been
sold by a manufacturing agency alone.72,73 Peruvoside, a cardiac
glycoside was isolated from Thevetia peruviana at the Indian labo-
ratory and developed in Germany.72 Taxol, potent anticancer drug
discovered from Taxus brevifolia, the plant has been utilized by
western Indian cultures as a medicine since long time.74
A national/international research discovered a number of drugs
from plant which has been used Indian traditional medicine since
ancient time, like, vasicine and vasicinone from Adhatoda vasica,
bacosoids from Bacopa monnieri, tylophorine from Tylophora indica,
homoharringtonine from Cephalotaxus, camptothecin from Camp-
totheca acuminate, conessine from Holarrhena antidysentrica,
morphine and codeine from Papaver som-niferum, sarsasapogenin,
asparanin A and asparanin B from Asparagus adscendens, shatavarin
from Asparagus racemosus, atropine from Atropa belladonna, gly-
cyrrhizin from Glycyrrhiza glabra, aloin from Aloe vera, protodioscinPlease cite this article in press as: Sen S, Chakraborty R, Revival, moderniz
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j.jtcme.2016.05.006from Tribulus terrestris, sophoradin from Sophora subprostrata,
quinine from Cinchona spp., trigonelline from Trigonella foenum-
graecum, catechin from Acacia catechu,withanolides fromWithania
somnifera, tinosporic acid from Tinospora cordifolia, cocaine from
Erythroxy-lum coca, aegelin and marmelosin from Aegle marmelos,
pris-timerin from Celastrus paniculata, asiaticoside from Centella
asiatica, emetine from Cephaelis ipecacuanha, psoralen from Psor-
alea corylifolia, glycyrrhizin from G. glabra, boeravinones from
Boerrhavia diffusa, berberine from Berberis aristata, plumbagin from
Plumbago indica, curcumin from Curcuma longa, podophyllin from
Podophyllum emodi, jatamansone from Nardostachys jatamansi,
quassinoids from Ailanthus spp., arjunolic acid from Terminalia
arjuna, gingerols from Zingiber ofﬁcinale, digoxin and digitoxin from
Digitalis lantana, paclitaxel from Taxus baccata and Taxus brevifolia,
allicin from Allium sativum, nimbidin from Azadirachta indica, for-
skolin from Coleus forskohlii, pilocarpine from Pilocarpus jaborandi,
Dysobinin from Dysoxylum binectariferum, Diosgenin from T. foe-
num-graecum and plants of Dioscorea spp., vinblastine and
vincristine from Catharanthus roseus and many more.17,75,76
Novel semisynthetic derivatives of rohitukine (from the plant
Amoora rohituka & D. binectariferum) named as ﬂavopiridol and P-
276-00 are in the advance clinical trial as anticancer drug.17 Gug-
gulu, an oleo-gum resin obtained from the bark of Commiphora
wightii has been used in Ayurveda for the treatment of inﬂamma-
tion, gout, rheumatism, obesity, and disorders of lipids metabolism.
Several compounds namely Z-guggulsterone, E-guggulsterone,
guggulsterol-I, guggulsterol-II etc. have been isolated from gug-
gulu.77 CSIR and its constituents laboratories are involved in the
development of new herbal drug or formulation. Some of the key
developments in Central Drug Research Institute (CDRI) in this area
are, (i) standardized fraction of gugulipid was developed by CDRI
and marketed (Guglip®, Cipla Ltd) as a drug for hyperlipidaemia
and atherosclerosis, (ii) arteether (a semisynthetic derivative of
artemisinin, the active constituent of Artemisia annua) as antima-
larial drug which is marketed by Themis Chemicals Ltd., Mumbai
under the trade name E-Mal, (iii) Consap (a local spermicidal
cream) contain saponins from Sapindus mukorossi, (iv) picroliv, an
iridoid glycoside mixture containing 60% picroside I and kutoside
obtained from Picrorhiza kurroa developed as hepatoprotective
agent, (v) a standardize herbal preparation derived from the plant
B. monnieri as memory enhancer.78 RRL Jammu has commercialized
Boswellia serrata gum resin as NSAID (non-steroidal anti-
inﬂammatory drug) (Sallaki® Guﬁc).79 A number of herbal pain
reliever, antifungal cream, anti-dandruff shampoo has been
developed by different CSIR labs across the country. Very recently,
an antidiabetic drug (BGR-34) has developed jointly developed by
scientist of CSIR-NBRI & CSIR-CIMAP. Under the ‘Golden Triangle
Partnership’ project between AYUSH, Indian Council of Medical
Research (ICMR), CSIR there is an attempt to ﬁnd few formulations
and developing new drugs.
In recent years research on these areas is increasing and lot
more drug/formulations investigated by public or private sector in
India are in queue or in under clinical trial. India has great pool of
diverse medicinal plant sources, a long and well characterized
traditional medicinal system which makes India a unique place of
new drug discovery.
6.6. Current science & technology in modernization of herbal
medicine
Global pharmaceutical companies and researchers equipped
with modern scientiﬁc knowledge, technology, idea and started to
rediscover medicinal plants as a source of new drug candidates
based on traditional knowledge.17,20 Modern technology and tech-
niques have revolutionized the progression of drug discovery fromation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
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key tool in the development of traditional medicine further.
Research utilizing modern equipments or methods helped us to
isolate and develop phytoconstituents as new drug present in
traditional herbal formulation or medicinal plants. Modern tech-
nology and techniques became an essential tool to monitor and
maintain the quality of traditional formulation, use phytochemical
as lead to discover new drugs, to ﬁnd pharmacokinetic proﬁle and
toxicity, to ﬁnd out mechanism, to ﬁnd the new use of existing drug
or formulation, acceleration of drug discovery process, synthetic
and semisynthetic process tomanufacture a natural constituent etc.
Ayurveda is one of the oldest and well documented health tra-
ditions in the world. Drug discovery based on traditional informa-
tion is a key path towards the discovery of new drug. Reverse
pharmacology is an approach where discovery of leads/formula-
tions is based on the documented clinical experiences and scientiﬁc
observations through series of studies. Reversepharmacology based
on traditional knowledge concentrate on the reversing routine
‘laboratory-to-clinic’ development to ‘clinics-to-laboratories’.
Safety is considered as most signiﬁcant point remains and the
effectiveness becomes a matter of validation. This process is highly
useful to ﬁnd better and safer leads.80 Fig. 2 describes the oppor-
tunity of drug discovery from Indian System of Medicine.
7. Towards the achievement of universal healthcare
In 21st century, tremendous advances in healthcare sector
coexist with inequities in accessibility, availability and affordability
of the healthcare facilities in many parts of the world. Since last few
decades, there is a growing interest in traditional medicine in allFig. 2. Opportunity of drug discovery from
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acceptance, relative low side effect and cost became the key factor
for the growth of traditional medicine.81 Of course, these also
provide us the opportunity to integrate such medicine in primary
healthcare to facilitate the people health. However, the path is not
so easy. A number of approaches have been formulated toward the
mainstreaming of traditional medicine in healthcare system.
‘Romantic approach’ suggested that traditional medicine is good as
such and should be remained as it is, ‘trans-cultural and trans-
disciplinary synergy approach’ support the fact that sciences
recognize that they stand for one type of knowledge among others
and that information is always culturally entrenched and forming
part of historic advance, ‘syncretic approach’ considered to be
merging two system to form a new system, in ‘complementarity
approach’ one system provides as supportive role to another.81 But
evidence based approach to utilize both conventional as well as
traditional medicine in conjunction could be the best option to
provide healthcare facility to all.
A number of case studies or surveys had shown the importance
of traditional medicine in primary healthcare service. A study in
rural area of West Bengal shows that folk medicine play a key role
to prevent common diseases likes small injuries, skin disease, fever,
dehydration, diabetes, high BP, liver disease etc in better way.82 In
rural areas of Meghalaya, indigenous medicine play signiﬁcant role
in primary healthcare for prevention/management of common
ailments.83 Another study reported the efﬁcacy of Ayurvedic
multimodal management in osteoarthritis, the study also proposed
that the Ayurvedic drugs can be an alternative of NSAIDs in such
treatment.84 Beneﬁcial effect of integration of Ayurveda with
modern system of medicine in tertiary care hospital forIndian traditional herbal medicine.
ation and integration of Indian traditional herbal medicine in clinical
and Complementary Medicine (2016), http://dx.doi.org/10.1016/
Fig. 3. Circle of life for achieving universal and quality life.
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treatment proved effective with respect to reducing the symptoms,
improving quality of life and reducing the side effect of allopathic
pain killers.85 Ayurveda also can be integrated in care for cancer. It
was also suggested that Ayurveda offers outstanding drugs and
treatments which can be easily included along with the main-
stream cancermedicines. Ayurvedic treatment is effective to reduce
the side effects of chemotherapy and to improve general well-being
of the patient.86 Herbal remedies are found most useful to manage
simple healthcare problems like fever, diarrhoea, dysentery, upper
respiratory tract infections, worm infestations, certain liver dis-
eases, hepatitis, anaemia, arthritis, few gynaecological problem
along with different communicable diseases such as malaria, HIV.86
In India, the ratio of the doctor-patient is 1:1700 if we consider
only allopathic doctors, the ratio will come to 1:800 if the AYUSH
practitioners are added. This is much better than the WHO
recommendation of 1:1000. At present, an acute shortage of allo-
pathic doctors exists in the India and in rural areas this problem is
higher and with very less presence in remote areas. AYUSH prac-
titioners however have a much wider presence in rural and remote
areas.878. Conclusion
Traditional medicine particularly herbal medicine playing
important role in maintain of health in rural and remote areas.
Inclusion of traditional herbal medicine in clinical practice will help
to achieve the target ‘health for all’ (Fig. 3). Indian traditional
medicine like Ayurveda and others have sound scientiﬁcPlease cite this article in press as: Sen S, Chakraborty R, Revival, moderniz
practice: Importance, challenges and future, Journal of Traditional
j.jtcme.2016.05.006background of effectiveness and also acknowledged by the recent
researches. Although efforts are needed to overcome barriers like
irrational use, quality control and standardization issues, high
pharmacovogilance etc. Stick implementation of rules, monitoring
and periodic revision of regulations are absolute necessary to
promote Indian traditional medicine. Overall, adequate knowledge
about the system, high quality clinical trial, proper information
about such drugs and their effectiveness among common people
required towards the promotion of such medicine. Integration of
Ayurvedic and others Indian traditional medicine in clinical prac-
tice will helpful to promote the health of the people who are unable
to access the modern medicine properly. Utilization of such medi-
cine along with conventional drug surly put more values to pro-
mote health or cure diseases in the better way. Therefore,
mainstreaming of ISM along with allopathic drugs and healthy
lifestyle will be helpful to provide healthcare service in best
possible way to all people not only in India but around the globe.References
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